entertainment -WSS

entertainment

author：focus 2025-10-02 17:35:03 - browse：3

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： After traumatic brain injury, life support decisions can use more time

WSS

1 dead, 9 hurt in July 4th fireworks explosion

Getting Alzheimer's drug Leqembi to patients can be a challenge

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Key Senate committee drafts bipartisan bill to stem drug shortages

H5N1 bird flu virus started spreading in cows in Texas in December

Orangutan used medicinal plant to treat wound, first time ever seen

explore

entertainment

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Close Medicare's dangerous gaps in addiction treatment coverage

Activists slam private health insurers over coverage restrictions

1 dead, 9 hurt in July 4th fireworks explosion

Duchenne breakthrough therapy leaves behind pioneering families

Key Senate committee drafts bipartisan bill to stem drug shortages

Duchenne breakthrough therapy leaves behind pioneering families

After traumatic brain injury, life support decisions can use more time

Dobbs anniversary: the lost opportunity of abortion as health care

FTC falls short on scrutinizing hospital mergers, study says

entertainment

Diversity in clinical trials starts with building trust, experts say

Why rehabilitation engineers need to center patients in their research

Churchill Downs extends trainer Bob Baffert's ban through 2024

NASA releases new images of 'fingerprint

4 dead, 2 in stable condition in Philadelphia shooting: Police

A timeline of the missing Titanic tourist submersible

Wikipedia

hotspot

hotspot

hotspot